[
    [
        {
            "time": "",
            "original_text": "医药生物行业跨市场周报:医保目录再调整启动,创新/抗癌/基药品种受益",
            "features": {
                "keywords": [
                    "医药生物",
                    "医保目录",
                    "调整",
                    "创新",
                    "抗癌",
                    "基药"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业跨市场周报:医保目录再调整启动,创新/抗癌/基药品种受益",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]